Scholars Central

EditorialPublished 2016

Metabolomics in Heart Failure Patients: Hype and Hope

Authors: Berezin AE

Biomarkers Journal

Volume 2 · Issue 3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Heart failure remains a leading cause of death in patients with established cardiovascular disease. The biomarkers reflecting staging and evolution of HF appear to be promised tool to risk stratification and target-based therapy. In the editorial adaptive metabolic transitions of HF with reduced and preserved left ventricular ejection fraction are considered. It has discussed the role of metabolites in the regulating function of the failing heart. The use of metabolites, i.e. polyamines, putrescine, spermidine, spermine, ornithine decarboxylase, and acylcarnitine, in patients with HF is considered. Future directions regarding molecular biology techniques, which substantially contribute to assay of metabolic profile in HF patients aimed improving clinical outcomes, response to the individualized therapy, are emphasized.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomarkers Journal
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Berezin AE”